NasdaqCM - Nasdaq Real Time Price USD
Dianthus Therapeutics, Inc. (DNTH)
19.11
-0.16
(-0.83%)
At close: 4:00:01 PM EDT
19.11
0.00
(0.00%)
After hours: 4:05:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.89 | -0.94 | -3.49 | -3.33 |
| Low Estimate | -0.93 | -0.98 | -3.53 | -3.44 |
| High Estimate | -0.86 | -0.91 | -3.45 | -3.21 |
| Year Ago EPS | -- | -- | -2.16 | -3.49 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 864.67k | 900.78k | 3.77M | 3.14M |
| Low Estimate | -- | -- | 1.16M | -- |
| High Estimate | 1.96M | 2.28M | 6.79M | 7.13M |
| Year Ago Sales | 1.86M | 2.17M | 6.24M | 3.77M |
| Sales Growth (year/est) | -53.59% | -58.53% | -39.56% | -16.58% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.55 | -0.6 | -0.76 | -0.71 |
| EPS Actual | -0.51 | -0.74 | -0.7 | -0.82 |
| Difference | 0.04 | -0.14 | 0.06 | -0.11 |
| Surprise % | 6.52% | -23.13% | 7.91% | -15.49% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.89 | -0.94 | -3.49 | -3.33 |
| 7 Days Ago | -0.8 | -0.85 | -3.16 | -2.95 |
| 30 Days Ago | -0.8 | -0.85 | -3.16 | -2.95 |
| 60 Days Ago | -0.8 | -0.85 | -3.16 | -2.95 |
| 90 Days Ago | -0.86 | -0.89 | -3.29 | -2.79 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DNTH | -- | -- | -61.31% | 4.73% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 5/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 3/12/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Initiated | TD Cowen: Buy | 12/20/2024 |
Related Tickers
ORKA Oruka Therapeutics, Inc.
10.62
+3.01%
SYRE Spyre Therapeutics, Inc.
15.40
+3.49%
APGE Apogee Therapeutics, Inc.
40.34
+1.08%
TRML Tourmaline Bio, Inc.
16.20
-2.59%
JBIO Jade Biosciences, Inc.
7.72
+3.98%
COGT Cogent Biosciences, Inc.
5.31
+6.63%
83B.F 3SBio Inc.
2.2400
+36.59%
ARTV Artiva Biotherapeutics, Inc.
2.1600
+6.93%
ATXS Astria Therapeutics, Inc.
4.2900
+0.70%
MLYS Mineralys Therapeutics, Inc.
16.10
+5.09%